150–300 mg/day of extract standardized to OPC.
Modestly lowers blood pressure and improves vascular markers in meta-analyses of trials.
View the study (meta-analysis) →⏱ 3 min read
Grape seed extract is a concentrated preparation obtained from the seeds of Vitis vinifera, particularly rich in oligomeric proanthocyanidins (OPCs), a family of complex polyphenols formed by the oligomerization of flavan-3-ol (catechin) units that give the extract an in vitro antioxidant profile markedly superior to that of vitamin C, vitamin E, or beta-carotene when measured by capacity to neutralize free radicals in controlled chemical systems; its clinical use has been studied mainly in peripheral vascular disease, venous insufficiency, mild hypertension, eye health, and cognitive performance, with heterogeneous but generally favorable data.
The commercial history of grape seed extract owes part of its popularity to "Pycnogenol" from French maritime pine bark (with a similar but distinct composition), a registered trademark that generated an entire category of OPC supplements with a partly shared but not identical clinical profile; commercial grape seed extracts vary enormously in standardization, bioavailability, and proanthocyanidin profile, a heterogeneity that makes it hard to extrapolate clinical results between different products and that requires attention to the specific ingredient used in each study to interpret the data correctly.
The indication with the strongest clinical support is chronic venous insufficiency of the lower limbs: several trials have shown significant reductions in edema, improvements in the sensation of heaviness, and reductions in ankle and calf circumference with doses of 150-300 milligrams daily of standardized extract for 4-12 weeks; the effects are comparable to those of some pharmacological venotonics (diosmin, micronized hesperidin) and position the extract as a reasonable option in mild to moderate stages.
In mild to moderate arterial hypertension, several small trials and a meta-analysis published in 2018 have shown modest reductions in systolic (4-8 mmHg) and diastolic (3-5 mmHg) blood pressure with doses of 150-300 milligrams daily for 6-12 weeks; the magnitudes are quantitatively smaller than those of pharmacological antihypertensives but clinically relevant as adjuncts in people with borderline readings or as a complement to lifestyle changes.
The extract's in vitro antioxidant profile translates partially into improvements in plasma antioxidant markers in vivo (reduced lipid peroxidation products, increased total antioxidant capacity) in controlled studies; these biochemical changes do not necessarily translate into demonstrated clinical benefits but provide a mechanistic basis for several of the postulated cardiovascular and dermatological applications.
In healthy adults and in people with mild cognitive impairment, several small studies have shown modest improvements in processing speed, attention, and memory with supplementation at 150-300 milligrams daily for 12 weeks, an indication consistent with the data on improved cerebral microcirculation and reduced oxidative stress associated with neuronal aging.
In mild to moderate diabetic retinopathy and in age-related macular degeneration, several studies have shown improvements in contrast sensitivity, visual acuity, and retinal microcirculation parameters with supplementation over months, an indication consistent with the activity on capillary microcirculation documented in other vascular beds.
The doses studied range from 100 to 300 milligrams daily of extract standardized to a minimum of 95 percent oligomeric proanthocyanidins, split into one or two doses with or without food; cheap non-standardized products may have variable OPC content and reduced clinical efficacy; the effect on microcirculation and venous insufficiency appears gradually and requires at least 4-6 weeks for clinical assessment.
Generally well tolerated; the adverse effects described are rare and mild (digestive discomfort, headache, occasionally itching or skin rash); people taking warfarin-type anticoagulants should be cautious because of a described mild antiplatelet effect that could increase bleeding risk; those taking antihypertensive drugs should monitor blood pressure because of possible potentiation of the hypotensive effect; people with autoimmune diseases should be theoretically cautious because of immunomodulatory activity documented in vitro; in pregnancy and breastfeeding the data are limited and avoidance is recommended as a precaution; premium products such as Pycnogenol are significantly more expensive than standard grape seed extract, and their differential clinical superiority is not well established.
Information, not medical advice. Scientific evidence reflects the quality of the studies.